Ocular myasthenia gravis

Sanadze A.G.; Sidnev D.V.; Tumurov D.A.; Afanasieva O.I.

doi:https://doi.org/10.17116/jnevro2023123091116

Sanadze A.G.

Buyanov City Clinical Hospital;
Scientific and Practical Psychoneurological Center;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-9882-3149

Sidnev D.V.

Scientific and Practical Psychoneurological Center

ORCID: 0000-0001-8217-8002

Tumurov D.A.

Buyanov City Clinical Hospital;
Scientific and Practical Psychoneurological Center;
Pirogov Russian National Research Medical University

ORCID: 0000-0001-7183-6209

Afanasieva O.I.

Buyanov City Clinical Hospital

ORCID: 0009-0006-9911-7226

Ocular myasthenia gravis

Authors:

Sanadze A.G., Sidnev D.V., Tumurov D.A., Afanasieva O.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(9): 116‑120

DOI: 10.17116/jnevro2023123091116

Read: 13453 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Sanadze AG, Sidnev DV, Tumurov DA, Afanasieva OI. Ocular myasthenia gravis. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(9):116‑120. (In Russ.)
https://doi.org/10.17116/jnevro2023123091116

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

New pathogenic treatments for myasthenia gravis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):31-38

Robotic and thoracoscopic surgeries for anterior mediastinal neoplasms. Pirogov Russian Journal of Surgery. 2025;(2):6-12

Endoscopic ultrasonography with transbronchial fine needle aspiration biopsy and thoracoscopic removal of ectopic middle mediastinal thymoma. P.A. Herzen Journal of Oncology. 2025;(2):41-46

Immediate results of thoracoscopic and open combined thymectomy: a two-center study. Pirogov Russian Journal of Surgery. 2025;(5):58-64

Simultaneous reconstruction using endoprosthesis and lower deepithelialized flap in prophylactic mastectomy. Plastic Surgery and Aesthetic Medicine. 2025;(2-2):16-24

Coexistence of bronchial asthma and myasthenia gravis. (Clinical case). Journal of Respiratory Medicine. 2025;(4):53-58

Abstract:

The article describes an urgent medical and social problem — the diagnosis and treatment of the ocular myasthenia gravis. Despite recent advances in the study of synaptic pathology, the diagnosis of the ocular form of myasthenia gravis remains a challenging problem. This is due to the poor information content of laboratory and electromyographic methods in the diagnosis of ocular myasthenia gravis, and the generalized myasthenia gravis manifests in 90% of cases by external ophthalmoplegia and ptosis. The article highlights the features of the diagnosis and differential diagnosis of ocular myasthenia gravis. Data on the course and features of the clinical presentation of the disease are presented. The importance of analyzing anamnestic data and clinical manifestations of the disease is emphasized. The article discusses modern approaches to the treatment of the ocular myasthenia gravis. The authors present clinical observations of 2 patients with ocular myasthenia gravis.

Keywords:

myasthenia gravis

ptosis

diplopia

extraocular muscles

Authors:

Sanadze A.G.

Buyanov City Clinical Hospital;
Scientific and Practical Psychoneurological Center;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-9882-3149

Sidnev D.V.

Scientific and Practical Psychoneurological Center

ORCID: 0000-0001-8217-8002

Tumurov D.A.

Buyanov City Clinical Hospital;
Scientific and Practical Psychoneurological Center;
Pirogov Russian National Research Medical University

ORCID: 0000-0001-7183-6209

Afanasieva O.I.

Buyanov City Clinical Hospital

ORCID: 0009-0006-9911-7226

Received:

11.05.2023

Accepted:

08.06.2023

Close metadata

References:

Kuzin MI, Gekht BM. Miasteniya. Published online, 1996. (In Russ.).
Lisak RP, Barchi RL. Myasthenia Gravis. M.: Meditsina; 1984:270:3. (In Russ.).
Sommer N, Melms A, Weller M, Dichgans J. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects. Doc Ophthalmol. 1993;84(4):309-333. https://doi.org/10.1007/BF01215447
Shuey NH. Ocular myasthenia gravis: a review and practical guide for clinicians. Clin Exp Optom. 2022;105(2):205-213. https://doi.org/10.1080/08164622.2022.2029683
Fortin E, Cestari DM, Weinberg DH. Ocular myasthenia gravis: an update on diagnosis and treatment. Curr Opin Ophthalmol. 2018;29(6):477-484. https://doi.org/10.1097/ICU.0000000000000526
Gekht BM, Lantsova VB, Sepp EK. Clinical significance of quantitative determination of antibodies in blood serum by interaction with a fragment of the muscle acetylcholine receptor in patients with myasthenia gravis. Zhurnal nevrologii i psikhiatrii. 2003;(2):34-37. (In Russ.).
Shcherbakova NI, Sanadze AG, Gekht BM, et al. Antibodies to the acetylcholine receptor in the diagnosis of myasthenia gravis and other forms associated with neuromuscular transmission pathology. Nevrologicheskij zhurnal. 2003;8(2):23-25. (In Russ.).
Sanadze AG, Sidnev DV, Karganov MYu, Shcherbakova NI. Antibodies to the acetylcholine receptor in patients with various clinical forms of myasthenia gravis and Lambert—Eaton myasthenic syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2006;106(1):53-57. (In Russ.).
Oda K, Ito Y. Myasthenia gravis: antibodies to acetylcholine receptor in ocular myasthenia gravis. J Neurol. 1981;225(4):251-258. https://doi.org/10.1007/BF00313297
Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 1971;38(6):497-537.
Vincent A, Beeson D, Lang B. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. Eur J Biochem. 2000;267(23):6717-6728. https://doi.org/10.1046/j.1432-1327.2000.01785.x
Andrews PI, Massey JM, Sanders DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology. 1993;43(5):977-982. https://doi.org/10.1212/wnl.43.5.977
Gunji K, Skolnick C, Bednarczuk T, et al. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients. Clin Immunol Immunopathol. 1998;87(3):276-281. https://doi.org/10.1006/clin.1998.4536
Kaminski HJ, Ruff RL. Insights into possible skeletal muscle nicotinic acetylcholine receptor (AChR) changes in some congenital myasthenias from physiological studies, point mutations, and subunit substitutions of the AChR. Ann N Y Acad Sci. 1993;681:435-450. https://doi.org/10.1111/j.1749-6632.1993.tb22928.x
Oda K. Differences in acetylcholine receptor-antibody interactions between extraocular and extremity muscle fibers. Ann N Y Acad Sci. 1993;681:238-255. https://doi.org/10.1111/j.1749-6632.1993.tb22889.x
Huijbers MG, Marx A, Plomp JJ, et al. Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):163-175. https://doi.org/10.1016/S1474-4422(21)00357-4
Chiarandini DJ, Davidowitz J. Structure and function of extraocular muscle fibers. Curr Top Eye Res. 1979;1:91-142.
Lantsova VB, Sepp EK. Application of the immunoblotting method for differential diagnosis of various forms of myasthenia gravis and endocrine ophthalmopathy. Byulleten’ eksperimental’noj biologii i meditsiny. 2005;140(10):478-480. (In Russ.).